Ausgewählte Studien

[No authors listed] [No authors listed] Ann Clin Lab Sci. 2022 May;52(3):511-525. Ann Clin Lab Sci. 2022. PMID: 35777803 Harmer B, Lee S, Duong TVH, …Den ganzen Artikel lesen

Sardana K, Sachdeva S. Sardana K, et al. J Cosmet Dermatol. 2022 Jan;21(1):85-98. doi: 10.1111/jocd.14436. Epub 2021 Sep 26. J Cosmet Dermatol. 2022. … Den ganzen Artikel lesen

The search for measurable predictors linked with negative health complications in psoriasisDen ganzen Artikel lesen

Background: The diagnosis of psoriasis may be missed or delayed in primary care settings. Aim: To examine trends in healthcare events before a …Den ganzen Artikel lesen

ZusammenfassungHintergrund und ZielsetzungVergleich der Wirksamkeit und Sicherheit von Biologika zur Behandlung mittelschwerer bis schwerer …Den ganzen Artikel lesen

Dermatol Ther. 2022 Sep 15:e15831. doi: 10.1111/dth.15831. Online ahead of print. ABSTRACT BACKGROUND: In many countries there are strong incentives for initiation of treatment with biosimilars in biologic-naïve patients and non-medical switch of ongoing treatment with originators, but real-world data regarding the outcome of these treatments are scarce. OBJECTIVES: The objective of this study is to analyze the drug survival of biosimilar adalimumab for treatment of psori

J Pharm Pharmacol. 2022 Aug 30:rgac058. doi: 10.1093/jpp/rgac058. Online ahead of print. ABSTRACT OBJECTIVES: Lupinus is a large and diverse genus comprising approximately 200 species, belonging to the family Fabaceae. Lupinus plants have been used for heart stimulants, nerves, urinary tract infections, skin disorders, and psoriasis in folk medicine. This review aims to recap the traditional medicinal uses, nutritional value, phytochemical profile, and biological activities of Lupinus species. K

logistic J Dermatolog Treat. 2022 Aug 18:1-12. doi: 10.1080/09546634.2022.2115285. Online ahead of print. ABSTRACT OBJECTIVES: Fumaric acid esters (FAEs) are a well-established treatment option for long-term therapy of moderate to severe plaque psoriasis. This study examines effectiveness of FAEs for the treatment of plaque psoriasis in real-world practice at 12 months and if patient characteristics affect the odds of clinical response. METHODS: A descriptive, mul

Am J Clin Dermatol. 2022 Aug 17. doi: 10.1007/s40257-022-00722-y. Online ahead of print. ABSTRACT BACKGROUND: Drug survival, defined as the length of time from initiation to discontinuation of a given therapy, allows comparisons between drugs, helps to predict patient's likelihood of remaining on a specific treatment, and achieving the best decision for each patient in daily clinical practice. OBJECTIVE: The aim of this study was to provide data on drug survival of secukinumab, ixekizumab, broda

Den ganzen Artikel lesen

Arthritis Rheumatol. 2022 Jul 29. doi: 10.1002/art.42315. Online ahead of print. ABSTRACT OBJECTIVE: To analyse the prevalence of spondyloarthritis (SpA) in patients with acute anterior uveitis (AAU), to identify parameters associated with SpA presence, and to evaluate referral algorithms. METHODS: Prospectively recruited consecutive patients with non-infectious AAU underwent structured rheumatologic assessment including magnetic resonance imaging of sacroiliac joints allowing a definitive diagn

J Clin Med. 2022 Jul 26;11(15):4328. doi: 10.3390/jcm11154328. ABSTRACT BACKGROUND AND OBJECTIVES: During the last decades, growing evidence corroborates that chronic inflammatory disease impairs the body beyond the cutaneous barrier. Linkage between psoriasis and kidney disease, and in particular between psoriasis and end-stage renal disease (ESRD), have not yet been elucidated. We sought to analyze the impact of concomitant psoriasis on the in-hospital outcomes of patients hospitalized with ES

Den ganzen Artikel lesen

Int J Dermatol. 2022 Jul 22. doi: 10.1111/ijd.16365. Online ahead of print. NO ABSTRACT PMID:35867958 | DOI:10.1111/ijd.16365 Den ganzen Artikel lesen

Eur J Dermatol. 2022 Apr 1;32(2):195-206. doi: 10.1684/ejd.2022.4222. ABSTRACT BACKGROUND: The COVID-19 pandemic has led to widespread changes in medical care. However, it is still unclear to what extent the care of patients suffering from moderate-to-severe psoriasis, chronic spontaneous urticaria or atopic dermatitis has been affected. OBJECTIVES: This study was conducted to determine the impact of the SARS-CoV-2 pandemic on medical care in dermatological practices, focusing on physicians’ con

Den ganzen Artikel lesen

Full text linksCite Display options Display options Background: Sleep, which is crucial for restoring of physiological functions and health, is …Den ganzen Artikel lesen

The physiology and pathology of the skin are influenced by daily oscillations driven by a master clock located in the brain, and peripheral clocks in …Den ganzen Artikel lesen

Am J Clin Dermatol. 2022 Jul;23(4):547-559. doi: 10.1007/s40257-022-00702-2. Epub 2022 Jul 20. ABSTRACT BACKGROUND: The efficacy and safety of tralokinumab, a fully human monoclonal antibody that specifically neutralizes interleukin-13, plus topical corticosteroids (TCS) as needed were evaluated over 32 weeks in the phase III ECZTRA 3 trial. Significantly more tralokinumab- versus placebo-treated patients achieved the primary endpoints of Investigator's Global Assessment (IGA) score of 0/1 and 7

Objective: To evaluate fatigue frequency and severity among patients with psoriatic arthritis (PsA) and assess the impact of fatigue severity on …Den ganzen Artikel lesen

Commentary on ‘perceived stress in four inflammatory skin diseases: An analysis of data taken from 7273 adult subjects with acne, psoriasis, atopic …Den ganzen Artikel lesen

Tumor necrosis factor inhibitors (TNFis) are commonly used for treating psoriatic diseases; however, the risk of infection while receiving TNFis …Den ganzen Artikel lesen

Br J Dermatol. 2022 Jul 12. doi: 10.1111/bjd.21763. Online ahead of print. NO ABSTRACT PMID:35819180 | DOI:10.1111/bjd.21763 Den ganzen Artikel lesen

Int J Mol Sci. 2022 Jul 5;23(13):7484. doi: 10.3390/ijms23137484. ABSTRACT Inflammatory diseases of the skin, including atopic dermatitis and psoriasis, have gained increasing attention with rising incidences in developed countries over the past decades. While bodily properties, such as immunological responses of the skin, have been described in some detail, interactions with the brain via different routes are less well studied. The suggested routes of the skin-brain axis comprise the immune sys

JMIR Form Res. 2022 Jul 7;6(7):e32593. doi: 10.2196/32593. ABSTRACT BACKGROUND: Psoriasis is a chronic disease characterized by inflammation, increased scaling, itching, and other symptoms. Psoriasis is not contagious, but patients have often felt shunned. Therefore, in addition to psoriasis symptoms, stress, anxiety, and depression can also affect quality of life (QoL). Surveys show that only a quarter of patients are satisfied with the success of their therapy. However, in addition to medical